NCT07609589

Brief Summary

Postpartum hemorrhage due to uterine atony is a major cause of maternal morbidity and mortality. This randomized controlled trial aims to compare the efficacy of uterine balloon tamponade and uterine gauze packing in controlling bleeding in women with postpartum hemorrhage. A total of 216 participants will be randomly assigned to one of the two treatment groups. All patients will receive standard medical management including uterotonic agents prior to intervention. The primary outcome is cessation of uterine bleeding within 24 hours after the procedure. This study aims to identify a safe and effective method for managing postpartum hemorrhage in a resource-limited setting.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
216

participants targeted

Target at P75+ for not_applicable

Timeline
6mo left

Started Jul 2026

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 15, 2026

Completed
12 days until next milestone

First Posted

Study publicly available on registry

May 27, 2026

Completed
1 month until next milestone

Study Start

First participant enrolled

July 1, 2026

Expected
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2026

11 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 10, 2027

Last Updated

May 27, 2026

Status Verified

May 1, 2026

Enrollment Period

6 months

First QC Date

May 15, 2026

Last Update Submit

May 21, 2026

Conditions

Keywords

postpartum hemorrhageuterine atonyballoon tamponadeuterine packing

Outcome Measures

Primary Outcomes (1)

  • Successful Control of Postpartum Hemorrhage Assessed by Cessation of Active Uterine Bleeding Without Need for Additional Surgical Intervention

    Successful control of postpartum hemorrhage will be defined as cessation of active uterine bleeding within 24 hours after uterine balloon tamponade or uterine gauze packing, without the need for additional surgical procedures (e.g., hysterectomy, arterial ligation, or repeat tamponade/packing), as assessed clinically by the treating obstetric team.

    24 hours after intervention

Study Arms (2)

Uterine Balloon Tamponade

EXPERIMENTAL
Procedure: Uterine Balloon Tamponade

Uterine Gauze Packing

ACTIVE COMPARATOR
Procedure: Uterine gauze packing

Interventions

Uterine balloon tamponade will be performed using sterile Foley catheters inserted into the uterine cavity and inflated with normal saline to achieve hemostasis in patients with postpartum hemorrhage due to uterine atony, following standard aseptic techniques.

Uterine Balloon Tamponade

Uterine gauze packing will be performed using sterile gauze placed within the uterine cavity and vagina to apply pressure and control bleeding in patients with postpartum hemorrhage due to uterine atony, following standard aseptic techniques.

Uterine Gauze Packing

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Women aged 18 to 40 years
  • Gestational age between 37 and 42 weeks
  • Parity up to 4
  • Diagnosed with postpartum hemorrhage due to uterine atony

You may not qualify if:

  • Postpartum hemorrhage due to perineal, cervical, or vaginal trauma
  • Retained products of conception
  • Vaginal delivery after previous cesarean section
  • Known coagulation disorders
  • Sepsis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Postpartum HemorrhageUterine Inertia

Interventions

Uterine Balloon Tamponade

Condition Hierarchy (Ancestors)

Obstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesPuerperal DisordersUterine HemorrhageHemorrhagePathologic ProcessesPathological Conditions, Signs and SymptomsDystocia

Intervention Hierarchy (Ancestors)

Balloon OcclusionCatheterizationTherapeuticsEndotamponadeHemostatic TechniquesEmbolization, TherapeuticTherapeutic OcclusionInvestigative Techniques

Central Study Contacts

Madiha Yar Khan

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 15, 2026

First Posted

May 27, 2026

Study Start (Estimated)

July 1, 2026

Primary Completion (Estimated)

December 30, 2026

Study Completion (Estimated)

January 10, 2027

Last Updated

May 27, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share